Topical Drug Delivery Market Analysis, Share and Size, Trends, Industry Growth And Segment Forecasts To 2022

New York, March 18, 2018:

Topical Drug Delivery Market 2018

The Global Topical Drug Delivery Market is expected to exceed more than US$ 126.00 Billion by 2022 at a CAGR of 6.0% in the given forecast period.

The scope of the report includes a detailed study of global and regional markets on Global Topical Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), Galderma S.A. (Switzerland), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

You Can Find Full Report @: https://www.marketresearchengine.com/topical-drug-delivery-market

The Global Topical Drug Delivery Market has been segmented as below:

By Product Type Analysis:
• Formulation
o Semi-solids
 Ointments
 Creams
 Gels
 Lotions
 Pastes
o Liquids
 Suspension
 Solutions
o Solids
 Powders
 Suppositories
• Devices (Transdermal Drug Delivery)
o Patches
•
o Gels

By Facility of Use Analysis:
• Hospitals and Private Clinics
• Home Care Settings
• Other Facilities of Use

By Route of Administration Analysis:
• Skin
• Ophthalmic
• Rectal
• Vaginal
• Nasal

By Regional Analysis:
• North America
• Europe
• Asia-Pacific
• Rest of the World

This report provides:

1) An overview of the global market for Global Topical Drug Delivery Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Topical Drug Delivery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Request Sample Report: https://www.marketresearchengine.com/topical-drug-delivery-market

Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Topical Drug Delivery Market, By Product Type
7 Topical Drug Delivery Market, By Route of Administration
7.1 Introduction
7.2 Skin Drug Delivery
7.3 Ophthalmic Drug Delivery
7.4 Rectal Drug Delivery
7.5 Vaginal Drug Delivery
7.6 Nasal Drug Delivery
8 Topical Drug Delivery Market, By Facility of Use
9 Topical Drug Delivery Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Glaxosmithkline PLC
11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
11.3 Novartis AG
11.4 Galderma S.A.
11.5 Valeant Pharmaceuticals International, Inc.
11.6 Bayer AG
11.7 3M Drug Delivery Systems
11.8 Crescita Therapeutics Inc.
11.9 Medpharm
11.10 Cipla

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.